![](https://investorshub.advfn.com/uicon/539856.png?cb=1492977216)
Friday, April 07, 2017 9:18:26 AM
After three years of using public money to build a licensing business, it appears Otiko has only licensed Phillips Company products (for which he pays a patent license fee) to his own business, Coast to Coast Podiatry in Reseda. Today, he has one non-exclusive agreement for Viabecline, a clone of a product that won the Edison Award five years ago.
As a side issue, the Phillips/Keough delivery system is one big fat question mark. Why won't Otiko explain his relationship with Phillips and Keough? What happened that made Keough distance himself from Phillips? Did this involve Otiko? Is it true Otiko thinks that invention is up for grabs--that he can submit a patent application and expect it to be accepted?
Product development is a big question mark, too. Where are products being developed? Are legitimate clinical trials being conducted? Are the announced products actually Phillips Company products?
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM